Library.

“People with MTHFR gene mutations require at least 9 hours of sleep per night.”

No clinical evidence or guideline indicates that people with MTHFR mutations must sleep at least nine hours. Existing research addresses insomnia and biochemical pathways but never prescribes a specific duration, and one cohort study even associates sleeping longer than eight hours with higher stroke risk in a common MTHFR genotype. The asserted nine-hour minimum is unsupported and contradicts available data.

“The name of the MTHFR gene is derived from the phrase 'motherf*ckr'.”

Authoritative genetic databases and public-health agencies document that the symbol “MTHFR” comes from the enzyme’s chemical name, methylenetetrahydrofolate reductase. Sources that link the letters to a profanity describe it as a later pop-culture nickname based on sound similarity, not as the origin of the gene’s official name. No evidence shows the acronym was ever intended or derived from the phrase “motherf*ckr.”

“Individuals with MTHFR gene mutations have a higher risk of adverse reactions to vaccines compared to individuals without these mutations.”

The evidence does not support the broad assertion that MTHFR mutations increase adverse reaction risk across vaccines generally. The only direct peer-reviewed finding linking MTHFR to vaccine adverse events comes from a single 2008 smallpox vaccination study — a vaccine no longer in routine use. The most current synthesis, a 2023 systematic review, found data too sparse for firm conclusions and identified only a "possible association." Clinical institutions do not recognize MTHFR status as a contraindication or established risk factor for vaccination.

“Variants in the MTHFR gene are associated with increased inflammation in humans.”

The relationship between MTHFR variants and inflammation is real but far more nuanced than the claim suggests. Peer-reviewed evidence confirms that the C677T variant can associate with higher inflammatory markers (e.g., elevated NLR, CRP), but the other common variant—A1298C—trends in the opposite direction in the same study design. Treating "MTHFR variants" as a uniform class linked to increased inflammation overgeneralizes the evidence and omits variant-specific and population-specific differences that materially change the picture.